Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Yohei Doi, MD, PHD (he/him/his)

Professor of Medicine
University of Pittsburgh
Toyoake, Aichi, Japan

Dr. Yohei Doi is Professor of Medicine and Director of the Center for Innovative Antimicrobial Therapy at the University of Pittsburgh and Professor of Microbiology and Infectious Diseases at Fujita Health University. His research focuses on mechanisms of antimicrobial resistance in highly drug-resistant Gram-negative bacterial pathogens and devising ways to overcome them. He has authored over 300 articles in peer-reviewed journals and mentored over 30 students and trainees in his laboratory. He currently chairs the Gram-negative committee of the Antibacterial Resistance Leadership Group.

Disclosure(s): AbbVie: Advisor/Consultant (Terminated, October 31, 2023); bioMerieux: Advisor/Consultant (Terminated, December 31, 2022); Entasis Pharmaceuticals: Grant/Research Support (Ongoing); FujiFilm: Advisor/Consultant (Terminated, December 31, 2022); Gilead: Advisor/Consultant (Terminated, November 30, 2023), Honoraria (Terminated, November 30, 2023); GlaxoSmithKline (GSK): Advisor/Consultant (Terminated, March 31, 2023); Meiji Seika Pharma: Advisor/Consultant (Ongoing); Moderna: Advisor/Consultant (Terminated, November 30, 2023); MSD: Advisor/Consultant (Terminated, December 31, 2022), Honoraria (Terminated, December 31, 2022); Pfizer, Inc.: Advisor/Consultant (Terminated, November 30, 2023); Shionogi: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing)

Presentation(s):